Engineered nucleases and, more recently, CRISPR have enhanced gene editing efficiency, acting as molecular scissors.
The evolution of genetic engineering has led to precise genome edits, moving away from random DNA insertions. Engineered nucleases and, more recently, CRISPR have enhanced gene editing efficiency, acting as molecular scissors. These advancements have broadened the scope of gene therapy, treating genetic disorders and other conditions by adding, replacing, or silencing specific genes.